<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM RAYTEL
MEDICAL CORPORATION AND SUBSIDIARIES FINANCIAL STATEMENTS AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 6,785
<SECURITIES> 0
<RECEIVABLES> 29,572<F1>
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 39,431
<PP&E> 48,009
<DEPRECIATION> 28,179
<TOTAL-ASSETS> 101,689
<CURRENT-LIABILITIES> 11,667
<BONDS> 0
0
0
<COMMON> 9
<OTHER-SE> 67,646
<TOTAL-LIABILITY-AND-EQUITY> 101,689
<SALES> 0
<TOTAL-REVENUES> 68,785
<CGS> 0
<TOTAL-COSTS> 65,806
<OTHER-EXPENSES> (53)<F3>
<LOSS-PROVISION> 0<F2>
<INTEREST-EXPENSE> 1,471
<INCOME-PRETAX> 1,561
<INCOME-TAX> 609
<INCOME-CONTINUING> 952
<DISCONTINUED> (4,960)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,008)
<EPS-BASIC> (0.46)
<EPS-DILUTED> (0.46)
<FN>
<F1>(RECEIVABLES) Represents net receivables.
<F2>(LOSS-PROVISION) Included in (TOTAL COSTS)
<F3>(OTHER-EXPENSES) Represents other income.
</FN>
</TABLE>